ARQT Institutional Ownership & Shareholders
ARCUTIS BIOTHERAPEUTICS INC (ARQT) is currently held by 284 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $3.42B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of ARQT tracked by InsiderSet, reporting ownership valued at approximately $326.10M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $398.85M, representing an estimated gain of +22.31% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 55% of the total disclosed ARQT value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Blackrock, Inc., Frazier Life Sciences Management, L.P., and several other long-term asset managers with concentrated positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT).
This page ranks the largest institutional ARQT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
284
Total Reported Value
$3.42B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$326.10M
Insider Transactions (90d)
24
Latest Filing Quarter
Q2 2026
New Institutional Positions
56
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Suvretta Capital Management, Llc | 6.85% | 12,437,000 | $326,098,140 | $398,854,590 | +$72,756,450 | +22.31% | |
| Blackrock, Inc. | 0.00% | 10,545,466 | $276,502,120 | $338,193,095 | +$61,690,975 | +22.31% | |
| Frazier Life Sciences Management, L.P. | 5.64% | 9,874,511 | $258,909,678 | $316,675,568 | +$57,765,890 | +22.31% | |
| Rubric Capital Management Lp | 1.99% | 8,271,577 | $216,880,749 | $265,269,474 | +$48,388,725 | +22.31% | |
| Polar Capital Holdings Plc | 0.49% | 6,606,945 | $173,234,098 | $211,884,726 | +$38,650,628 | +22.31% | |
| State Street Corp | 0.00% | 5,822,840 | $152,674,865 | $186,738,479 | +$34,063,614 | +22.31% | |
| Vanguard Capital Management Llc | 0.00% | 4,988,756 | $130,805,182 | $159,989,405 | +$29,184,223 | +22.31% | |
| Morgan Stanley | 0.01% | 4,451,014 | $116,705,607 | $142,744,019 | +$26,038,412 | +22.31% | |
| Jennison Associates Llc | 0.07% | 4,219,058 | $110,623,703 | $135,305,190 | +$24,681,487 | +22.31% | |
| D. E. Shaw & Co., Inc. | 0.06% | 3,949,609 | $103,558,748 | $126,663,961 | +$23,105,213 | +22.31% | |
| Ubs Group Ag | 0.01% | 3,333,015 | $87,391,654 | $106,889,791 | +$19,498,137 | +22.31% | |
| Bank Of America Corp | 0.01% | 2,987,431 | $78,330,441 | $95,806,912 | +$17,476,471 | +22.31% | |
| Geode Capital Management, Llc | 0.00% | 2,982,446 | $78,214,092 | $95,647,043 | +$17,432,951 | +22.29% | |
| Vanguard Portfolio Management Llc | 0.00% | 2,429,005 | $63,688,511 | $77,898,190 | +$14,209,679 | +22.31% | |
| Orbimed Advisors Llc | 1.01% | 2,042,000 | $53,541,240 | $65,486,940 | +$11,945,700 | +22.31% | |
| American Century Companies Inc | 0.02% | 1,925,031 | $50,474,363 | $61,735,744 | +$11,261,381 | +22.31% | |
| Goldman Sachs Group Inc | 0.00% | 1,668,367 | $43,744,582 | $53,504,530 | +$9,759,948 | +22.31% | |
| Janus Henderson Group Plc | 0.02% | 1,854,566 | $43,684,303 | $59,475,932 | +$15,791,629 | +36.15% | |
| Oberweis Asset Management Inc/ | 0.74% | 1,372,941 | $35,998,513 | $44,030,218 | +$8,031,705 | +22.31% | |
| Gilder Gagnon Howe & Co Llc | 0.36% | 1,313,211 | $34,432,392 | $42,114,677 | +$7,682,285 | +22.31% | |
| Gw&K Investment Management, Llc | 0.26% | 1,288,018 | $33,772,000 | $41,306,737 | +$7,534,737 | +22.31% | |
| Pivotal Bioventure Partners Investment Advisor Llc | 10.78% | 1,265,283 | $33,175,720 | $40,577,626 | +$7,401,906 | +22.31% | |
| Bamco Inc | 0.05% | 1,253,120 | $32,856,806 | $40,187,558 | +$7,330,752 | +22.31% | |
| Citadel Advisors Llc | 0.02% | 1,160,014 | $30,415,567 | $37,201,649 | +$6,786,082 | +22.31% | |
| Federated Hermes, Inc. | 0.04% | 1,124,629 | $29,487,772 | $36,066,852 | +$6,579,080 | +22.31% | |
| Ensign Peak Advisors, Inc | 0.05% | 1,244,387 | $29,317,758 | $39,907,491 | +$10,589,733 | +36.12% | |
| Aberdeen Group Plc | 0.04% | 1,098,411 | $28,800,336 | $35,226,041 | +$6,425,705 | +22.31% | |
| Jones Hill Capital Lp | 6.07% | 1,089,701 | $28,571,960 | $34,946,711 | +$6,374,751 | +22.31% | |
| Northern Trust Corp | 0.00% | 1,058,575 | $27,755,837 | $33,948,500 | +$6,192,663 | +22.31% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,050,934 | $27,555,489 | $33,703,453 | +$6,147,964 | +22.31% | |
| Perpetual Ltd | 0.39% | 958,843 | $25,342,221 | $30,750,095 | +$5,407,874 | +21.34% | |
| Candriam S.C.A. | 0.11% | 949,839 | $24,880,817 | $30,461,337 | +$5,580,520 | +22.43% | |
| Driehaus Capital Management Llc | 0.13% | 878,426 | $23,032,330 | $28,171,122 | +$5,138,792 | +22.31% | |
| Simplify Asset Management Inc. | 0.39% | 865,862 | $22,884,733 | $27,768,194 | +$4,883,461 | +21.34% | |
| Nuveen, Llc | 0.01% | 834,261 | $21,874,324 | $26,754,750 | +$4,880,426 | +22.31% | |
| Vanguard Fiduciary Trust Co | 0.00% | 815,138 | $21,372,918 | $26,141,476 | +$4,768,558 | +22.31% | |
| Manufacturers Life Insurance Company, The | 0.02% | 811,752 | $21,284,137 | $26,032,887 | +$4,748,750 | +22.31% | |
| Two Sigma Investments, Lp | 0.01% | 663,877 | $17,406,855 | $21,290,535 | +$3,883,680 | +22.31% | |
| Fishman Jay A Ltd/Mi | 1.27% | 597,115 | $15,781,749 | $19,149,478 | +$3,367,729 | +21.34% | |
| Millennium Management Llc | 0.01% | 564,072 | $14,789,968 | $18,089,789 | +$3,299,821 | +22.31% | |
| Bnp Paribas Financial Markets | 0.01% | 547,278 | $14,349,629 | $17,551,205 | +$3,201,576 | +22.31% | |
| Squarepoint Ops Llc | 0.03% | 537,747 | $14,099,726 | $17,245,546 | +$3,145,820 | +22.31% | |
| Capitolis Liquid Global Markets Llc | 0.06% | 500,000 | $13,110,000 | $16,035,000 | +$2,925,000 | +22.31% | |
| Nearwater Capital Markets, Ltd | 0.22% | 486,700 | $12,761,274 | $15,608,469 | +$2,847,195 | +22.31% | |
| Adage Capital Partners Gp, L.L.C. | 0.02% | 466,000 | $12,218,520 | $14,944,620 | +$2,726,100 | +22.31% | |
| Marshall Wace, Llp | 0.01% | 446,866 | $11,716,827 | $14,330,993 | +$2,614,166 | +22.31% | |
| Privium Fund Management B.V. | 1.92% | 399,367 | $10,471,403 | $12,807,700 | +$2,336,297 | +22.31% | |
| Norges Bank | 0.00% | 392,300 | $10,286,106 | $12,581,061 | +$2,294,955 | +22.31% | |
| Deutsche Bank Ag\ | 0.00% | 382,682 | $10,033,923 | $12,272,612 | +$2,238,689 | +22.31% | |
| Patient Square Capital Lp | 1.50% | 370,000 | $9,701,400 | $11,865,900 | +$2,164,500 | +22.31% |
Frequently asked questions about ARQT
Who are the largest institutional holders of ARQT?
The largest institutional holders of ARQT reported in the latest SEC Form 13F filings include Suvretta Capital Management, Llc, Blackrock, Inc., Frazier Life Sciences Management, L.P., Rubric Capital Management Lp, and Polar Capital Holdings Plc. InsiderSet ranks institutional holders by their latest reported ARQT position.
What is ARQT institutional ownership?
This page tracks ARQT positions reported by institutional investment managers through SEC Form 13F. ARCUTIS BIOTHERAPEUTICS INC (ARQT) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own ARQT?
InsiderSet currently tracks 284 institutional managers reporting ARQT holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of ARQT shareholders.
How much ARQT stock do institutions own?
Institutional investment managers disclosed approximately $3.42B in ARQT holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was ARQT institutional ownership last updated?
The latest ARQT institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional ARQT holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its ARQT position after the reporting date.
Are institutions buying or selling ARQT?
Institutional buying and selling can be analyzed by comparing ARQT positions across consecutive 13F reporting periods. InsiderSet's ARQT Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View ARQT ownership changes.
How has ARQT institutional ownership changed over time?
InsiderSet tracks ARQT institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.